Pacific Biosciences Of Stock Price Prediction
| PACB Stock | USD 1.93 0.02 1.05% |
Oversold Vs Overbought
36
Oversold | Overbought |
Using Pacific Biosciences hype-based prediction, you can estimate the value of Pacific Biosciences of from the perspective of Pacific Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pacific Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Pacific because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pacific Biosciences after-hype prediction price | USD 1.93 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pacific |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pacific Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Pacific Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pacific Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pacific Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pacific Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Pacific Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pacific Biosciences' historical news coverage. Pacific Biosciences' after-hype downside and upside margins for the prediction period are 0.10 and 8.61, respectively. We have considered Pacific Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pacific Biosciences is dangerous at this time. Analysis and calculation of next after-hype price of Pacific Biosciences is based on 3 months time horizon.
Pacific Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pacific Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pacific Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pacific Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.81 | 6.68 | 0.00 | 0.11 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.93 | 1.93 | 0.00 |
|
Pacific Biosciences Hype Timeline
Pacific Biosciences is at this time traded for 1.93. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.11. Pacific is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.81%. %. The volatility of related hype on Pacific Biosciences is about 4858.18%, with the expected price after the next announcement by competition of 1.82. About 83.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.24. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pacific Biosciences has Price/Earnings (P/E) ratio of 197.88. The entity recorded a loss per share of 1.46. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Pacific Biosciences Basic Forecasting Models to cross-verify your projections.Pacific Biosciences Related Hype Analysis
Having access to credible news sources related to Pacific Biosciences' direct competition is more important than ever and may enhance your ability to predict Pacific Biosciences' future price movements. Getting to know how Pacific Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pacific Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TWST | Twist Bioscience Corp | 0.00 | 0 per month | 3.52 | 0.08 | 8.94 | (6.21) | 17.59 | |
| NTLA | Intellia Therapeutics | (0.50) | 10 per month | 0.00 | (0.14) | 5.01 | (7.15) | 27.28 | |
| CRSP | Crispr Therapeutics AG | 0.00 | 0 per month | 2.26 | 0.08 | 6.28 | (3.21) | 16.95 | |
| EDIT | Editas Medicine | (0.05) | 10 per month | 0.00 | (0.20) | 7.41 | (6.68) | 24.40 |
Pacific Biosciences Additional Predictive Modules
Most predictive techniques to examine Pacific price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacific using various technical indicators. When you analyze Pacific charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pacific Biosciences Predictive Indicators
The successful prediction of Pacific Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pacific Biosciences of, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pacific Biosciences based on analysis of Pacific Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pacific Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pacific Biosciences's related companies.
Story Coverage note for Pacific Biosciences
The number of cover stories for Pacific Biosciences depends on current market conditions and Pacific Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pacific Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pacific Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pacific Biosciences Short Properties
Pacific Biosciences' future price predictability will typically decrease when Pacific Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pacific Biosciences of often depends not only on the future outlook of the potential Pacific Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pacific Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 253.6 M | |
| Cash And Short Term Investments | 631.4 M |
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |